Concepedia

Thomas P. Buters

TP

4

Publications

93

Citations

4

H-Index

2020

Active since

Affiliations

Centre for Human Drug Research(Current)

Leiden University Medical Center

Erasmus University Rotterdam

University College London

Leiden University

Thomas P. Buters is an author at Centre for Human Drug Research specializing in clinical symptoms, allergy, and antibiotics.

ORCID

Top concepts

Publications per year

2020–2021

4

Publications

4

Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial

Tessa Niemeyer‐van der Kolk, Thomas P. Buters, Lara Krouwels et al. · Journal of the American Academy of Dermatology · 2020 · 40 citations · Full text

, , +7

Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers

Thomas P. Buters, Pieter W. Hameeteman, Iris M. E. Jansen et al. · British Journal of Clinical Pharmacology · 2021 · 22 citations · Full text

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers

Tessa Niemeyer‐van der Kolk, Salma Assil, Thomas P. Buters et al. · Clinical and Translational Science · 2020 · 21 citations · Full text

Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers

Thomas P. Buters, Pieter W. Hameeteman, Iris M. E. Jansen et al. · Clinical Pharmacology & Therapeutics · 2021 · 10 citations · Full text

Rows per page

1–4 of 4